Q1 EPS Estimates for Legend Biotech Reduced by William Blair
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Analysts at William Blair lowered their Q1 2025 earnings estimates for Legend Biotech in a research report issued to clients and investors on Wednesday, March 12th. William Blair analyst S. Corwin now expects that the company will post earnings per share of ($0.40) for the quarter, down […]
